DNA framework-engineered chimeras platform enables selectively targeted protein degradation

[1]  I. Willner,et al.  Single-Stranded DNA-Encoded Gold Nanoparticle Clusters as Programmable Enzyme Equivalents. , 2022, Journal of the American Chemical Society.

[2]  C. Crews,et al.  Hijacking Methyl Reader Proteins for Nuclear-Specific Protein Degradation. , 2022, Journal of the American Chemical Society.

[3]  D. Langley,et al.  PROTAC targeted protein degraders: the past is prologue , 2022, Nature Reviews Drug Discovery.

[4]  Jinyun Dong,et al.  Protein degradation technology: a strategic paradigm shift in drug discovery , 2021, Journal of Hematology & Oncology.

[5]  Xing Wu,et al.  DNA Balance for Native Characterization of Chemically Modified DNA. , 2021, Journal of the American Chemical Society.

[6]  Jie Song,et al.  DNA Nanostructure-Programmed Cell Entry via Corner Angle-Mediated Molecular Interaction with Membrane Receptors. , 2021, Nano letters.

[7]  Yundong He,et al.  Destruction of DNA‐Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG , 2021, Advanced science.

[8]  Nancy Murphy,et al.  Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity , 2021, Nature Chemical Biology.

[9]  Guoqiang Dong,et al.  Aptamer-PROTAC Conjugates (APCs) for Tumor-specific Targeting in Breast Cancer. , 2021, Angewandte Chemie.

[10]  Y. Xiong,et al.  Advancing targeted protein degradation for cancer therapy , 2021, Nature Reviews Cancer.

[11]  J. L. La Clair,et al.  Unraveling the Role of Linker Design in Proteolysis Targeting Chimeras. , 2021, Journal of medicinal chemistry.

[12]  Wenyi Wei,et al.  Cancer Selective Target Degradation by Folate-Caged PROTACs. , 2021, Journal of the American Chemical Society.

[13]  Da Han,et al.  Bispecific Aptamer Chimeras Enable Targeted Protein Degradation on Cell Membranes. , 2021, Angewandte Chemie.

[14]  Lixia Chen,et al.  Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP. , 2021, Journal of medicinal chemistry.

[15]  Xiaoyu Li,et al.  Selection of DNA-encoded chemical libraries against endogenous membrane proteins on live cells , 2020, Nature Chemistry.

[16]  Jie Ren,et al.  Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion. , 2020, European journal of medicinal chemistry.

[17]  Jonathan Hall,et al.  RNA‐PROTACs: Degraders of RNA‐Binding Proteins , 2020, Angewandte Chemie.

[18]  M. Baud,et al.  Current strategies for the design of PROTAC linkers: a critical review , 2020, Exploration of targeted anti-tumor therapy.

[19]  D. Young,et al.  Design and Applications of Bifunctional Small Molecules in Biology. , 2020, Biochimica et biophysica acta. Proteins and proteomics.

[20]  C. Fan,et al.  PolyA-based DNA bonds with programmable bond length and bond energy , 2020, NPG Asia Materials.

[21]  D. Lane,et al.  bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA) , 2020, Proceedings of the National Academy of Sciences.

[22]  Veikko Linko,et al.  Challenges and Perspectives of DNA Nanostructures in Biomedicine , 2020, Angewandte Chemie.

[23]  Wenyi Wei,et al.  PROTACs: a novel strategy for cancer therapy. , 2020, Seminars in cancer biology.

[24]  Hao Yan,et al.  Programming nanoparticle valence bonds with single-stranded DNA encoders , 2019, Nature Materials.

[25]  J. Chao,et al.  Quantizing single-molecule surface-enhanced Raman scattering with DNA origami metamolecules , 2019, Science Advances.

[26]  C. Crews,et al.  PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future. , 2019, Drug discovery today. Technologies.

[27]  Chunhai Fan,et al.  Concept and Development of Framework Nucleic Acids. , 2018, Journal of the American Chemical Society.

[28]  H. Sleiman,et al.  Kinetics of Strand Displacement and Hybridization on Wireframe DNA Nanostructures: Dissecting the Roles of Size, Morphology, and Rigidity. , 2018, ACS nano.

[29]  C. Crews,et al.  Enhancing Antiproliferative Activity and Selectivity of a FLT-3 Inhibitor by Proteolysis Targeting Chimera Conversion. , 2018, Journal of the American Chemical Society.

[30]  Yuqing Huang,et al.  DNA Octahedron-Based Fluorescence Nanoprobe for Dual Tumor-Related mRNAs Detection and Imaging. , 2018, Analytical chemistry.

[31]  D. Maiti,et al.  Diverse meta-C-H Functionalization of Arenes across Different Linker Lengths. , 2018, Angewandte Chemie.

[32]  M. Zhang,et al.  A Telomerase-Responsive DNA Icosahedron for Precise Delivery of Platinum Nanodrugs to Cisplatin-Resistant Cancer. , 2018, Angewandte Chemie.

[33]  Chunhai Fan,et al.  DNA Nanotechnology-Enabled Drug Delivery Systems. , 2018, Chemical reviews.

[34]  I. Churcher.  Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones? , 2017, Journal of medicinal chemistry.

[35]  N. Bahlis,et al.  A General Strategy for the Preparation of Thalidomide-Conjugate Linkers , 2017, Synlett.

[36]  Alessandro Desideri,et al.  A Simple and Fast Semiautomatic Procedure for the Atomistic Modeling of Complex DNA Polyhedra , 2016, J. Chem. Inf. Model..

[37]  Jiye Shi,et al.  Single-particle tracking and modulation of cell entry pathways of a tetrahedral DNA nanostructure in live cells. , 2014, Angewandte Chemie.

[38]  Chunhai Fan,et al.  Designed diblock oligonucleotide for the synthesis of spatially isolated and highly hybridizable functionalization of DNA-gold nanoparticle nanoconjugates. , 2012, Journal of the American Chemical Society.

[39]  Paul Labute,et al.  Variability in docking success rates due to dataset preparation , 2012, Journal of Computer-Aided Molecular Design.

[40]  G. Papoian,et al.  Is DNA's rigidity dominated by electrostatic or nonelectrostatic interactions? , 2011, Journal of the American Chemical Society.

[41]  Dor Ben-Amotz,et al.  Unraveling water's entropic mysteries: a unified view of nonpolar, polar, and ionic hydration. , 2008, Accounts of chemical research.